Cell-of-Origin Subtypes and Therapeutic Benefit from Polatuzumab VedotinAdam C. Palmer,David M. Kurtz,Ash A. AlizadehNEW ENGLAND JOURNAL OF MEDICINE（2023）引用 0|浏览1暂无评分关键词polatuzumab vedotin,therapeutic benefit,cell-of-originAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
